BioCatch adds Sallie Krawcheck and Liat Nadai Arad to its Board of Directors

– ISRAEL, Tel Aviv-Yafo –  BioCatch, the global leader in digital fraud and money laundering detection and response powered by behavioral biometric intelligence, today announced the addition of Sallie Krawcheck and Liat Nadai Arad to its board of directors, bringing more than 50 years of growth, operations, and innovation experience in support of expanding fraud detection and financial crime prevention product portfolio and market growth strategies.

“Sally and Liat each bring incredible entrepreneurial energy, operational perspective, and growth experience that will invigorate our board room with insights, ideas, and opportunities,” said CEO Gadi Mazor. “Sallie’s business acumen and creativity, as well as her time in the trenches with some the world’s leading financial brands, will undoubtedly challenge our growth strategies while Liat’s digital transformation and cyber security expertise will drive us to expand our innovation initiatives. It is gives me great pleasure to welcome both Sallie and Liat to our Board of Directors.”

About Sallie Krawcheck

Sallie Krawcheck is the CEO and co-founder of Ellevest, an invest-tech and wealth management company, built by women, for women. She is one of the few financial executives of her generation to have found success both in large, global companies and as a start-up CEO. Before launching Ellevest, Krawcheck served as CEO of Merrill Lynch Wealth Management, Smith Barney, US Trust, Citi Private Bank, and Sanford C. Bernstein. She was also CFO for Citigroup. Before her multiple executive leadership roles, Krawcheck was a top-ranked research analyst covering the securities industry. She is also the best-selling author of “Own It: The Power of Women at Work,” is considered one of the “Most Influential People in ESG Investing” by Barron’s, and was named the seventh most powerful woman in the world by Forbes.

“I try to be thoughtful in choosing the organizations that I work with in today’s fast-moving financial technology landscape,” said Sallie Krawcheck. “For me, a company’s mission and its commitment to inclusion are as, if not more, important than technology-fit and revenue growth. BioCatch prioritizes all of these in its mission to protect banks and their customers from digital fraud and financial crime. I’m looking forward to working closely with Gadi, his team and my fellow board members in BioCatch’s mission to fight fraud and stop the financial crimes that threaten consumers’ personal security and peace of mind.”

About Liat Nadai Arad

Liat Nadai Arad is the Chief Transformation Officer at the Tel Aviv Medical Center, where she focuses on revolutionizing Israel’s public healthcare capabilities utilizing data and data science. Before joining the Tel Aviv Medical Center, Ms. Arad applied her unique combination of senior leadership, technology, and operations experience as the first-ever female Colonel to hold an operational technology role within the Israeli Defense Forces Unit 8200, where she served as Head of the Cyber Department. A highly decorated leader and officer, Ms. Arad was selected by Global Business Magazine as one of the ’50 Most Influential Women of Israel’ in 2022 and in 2021 was awarded the Israel Defense Award. Earlier in her career, Ms. Liat Nadai Arad served as a Board Member and VP at modu as well as VP at msystems, which was acquired by SanDisk Corp for $1.6B.

“As a long time cyber security practitioner and executive it is clear to me that we as humans may very well hold the key to our own safety and security online,” said Liat Nadai Arad. “Our behavior is unique, no one of us is the same, and the nuances in how we interact with technology makes us one of a kind. BioCatch’s data science in the area of behavioral biometric intelligence is truly next-generational and offers banks, and their customers, the power to improve online identity authentication, strengthen transactional security, and streamline their experience all by simply being themselves. I’m excited to work with the BioCatch team as they embark on the next phase of their journey.”

About BioCatch

BioCatch stands at the forefront of digital fraud detection, pioneering behavioral biometric intelligence grounded in advanced cognitive science and machine learning. BioCatch analyzes thousands of user interactions to support a digital banking environment where identity, trust and ease coexist. Today, more than 25 of the world’s leading 100 banks and 150 of the largest 500 rely on BioCatch Connect to combat fraud, facilitate digital transformation, and grow customer relationships. BioCatch’s Client Innovation Board, an industry-led initiative featuring American Express, Barclays, Citi Ventures, HSBC, and National Australia Bank, collaborates to pioneer creative and innovative ways to leverage customer relationships for fraud prevention. With more than a decade of data analysis, 90 registered patents, and unmatched expertise, BioCatch continues to lead innovation to address future challenges.

For more information:

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.